![Christopher Vann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 359 435 $ al 31/05/2026
Christopher Vann currently works at Alliance for Regenerative Medicine, as Treasurer & Director from 2023 and Autolus Therapeutics Plc, as Chief Operating Officer & Senior Vice President from 2016.
Mr. Vann also formerly worked at Roche Holding AG, as Commercial Director from 1994 to 2016.
Mr. Vann received his undergraduate degree from School of Pharmacy.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC 0,12 % | 18/03/2026 | 192.211 ( 0,12 % ) | 359 435 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Director de Operaciones | 01/10/2016 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | 01/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/09/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
School of Pharmacy
 School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
